Noteworthy, FGL1 is positively associated with CD4+ T cell levels within the tumor, while it can also support the expression of CD3D and prevent that of FOXP3; hence, FGL1 may support T cell tumor infiltration and function in the cancer microenvironment. The gene discussed is CD3D; the disease is cancer.